跳至主要内容
临床试验/CTRI/2012/05/002667
CTRI/2012/05/002667已完成3 期

The role of indigenous medicinal products in reducing the relapse rate of head and neck cancers a randomized controlled pilot study. - NI

Kerala State Council for Science Technology and Environment0 个研究点目标入组 100 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Subjects aged 25 â?? 70 years with head and neck cancers, in complete remission on two consecutive visits after the completion of radical radiotherapy ± chemotherapy will be eligible

排除标准

  • Patients with any one or more of the following condition,
  • Hypertension and Diabetes
  • Performance status 3 or more
  • Serum cholesterol above 250mg%
  • History of liver disease (hepatitis, cirrhosis liver)
  • History of ischemic heart disease including angina
  • Kidney disease (urine albumin +, blood urea above 50mg%)
  • Mental illness
  • Pregnant women
  • Unwillingness to participate in the study

研究者

发起方
Kerala State Council for Science Technology and Environment

相似试验